Health and Fitness
Health and Fitness
Mon, January 10, 2011
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
[ Mon, Jan 10th 2011
] - Market Wire
Sun, January 9, 2011
[ Sun, Jan 09th 2011
] - Market Wire
[ Sun, Jan 09th 2011
] - Market Wire
[ Sun, Jan 09th 2011
] - Market Wire
Fri, January 7, 2011
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
[ Fri, Jan 07th 2011
] - Market Wire
Biogen Idec nombra a Doug Williams Vicepresidente ejecutivo I+D y a Steven Holtzman Vicepresidente ejecutivo de desarrollo corp
WESTON, Massachussets--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) ha comunicado que Douglas E. Williams, Ph.D., ha sido nombrado Vicepresidente ejecutivo de investigacin y desarrollo (I+D), y Steven H. Holtzman ha sido nombrado Vicepresidente ejecutivo de desarrollo corporativo. El Dr. Williams supervisar las operaciones globales de I+D de la empresa, incluidas las operaciones clnicas, de desarrollo e investigacin de descubrimientos as como asuntos normativos.
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.
Contributing Sources